AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19228402 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 weeks of a twice‐weekly 90‐minute yoga class
Number of subjects: 59
Study 19228402 — intervention group
Group type: COMPARATOR
Intervention: Waiting list for yoga classes
Number of subjects: 59
Study 17710014 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary prevention program
Number of subjects: 162
Study 17710014 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise prevention program
Number of subjects: 162
Study 17710014 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 162
Study 15001682 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor testing (CPT)
Number of subjects: 56
Study 11553000 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF‐mobilized peripheral blood stem cell (PBSC) grafts
Number of subjects: 0
Study 11553000 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF mobilization
Number of subjects: 0
Study 11553000 — intervention group
Group type: COMPARATOR
Intervention: Bone marrow (BM) grafts
Number of subjects: 0
Study 9559614 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim 75 microg
Number of subjects: 61
Study 9559614 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim 300 microg
Number of subjects: 61
Study 9559614 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 7934737 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire submitted immediately after Clinical Psychiatry examination (224 students)
Number of subjects: 290
Study 7934737 — intervention group
Group type: COMPARATOR
Intervention: Questionnaire mailed (66 students)
Number of subjects: 290
Study 7934737 — intervention group
Group type: EXPERIMENTAL
Intervention: Female students
Number of subjects: 290
Study 7934737 — intervention group
Group type: EXPERIMENTAL
Intervention: Students considering psychiatry as a specialization
Number of subjects: 290
Study 7934737 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical students
Number of subjects: 290
Study 3148180 — intervention group
Group type: EXPERIMENTAL
Intervention: bupranolol
Number of subjects: 20
Study 3148180 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 29588861 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional standing frame programme (prolonged standing and repeated sit to stand)
Number of subjects: 50
Study 29588861 — intervention group
Group type: COMPARATOR
Intervention: Usual physiotherapy
Number of subjects: 50
Study 28571470 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-subsampled Contourlet transform (NSCT) combined with nonlinear enhancement function
Number of subjects: 0
Study 28571470 — intervention group
Group type: COMPARATOR
Intervention: CT method (Control)
Number of subjects: 0
Study 26337688 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention combining biological, cognitive behavioral, and psychophysiological techniques
Number of subjects: 714
Study 26337688 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 714
Study 23999933 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg daily for 104 weeks
Number of subjects: 613
Study 23999933 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 613
Study 20970213 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion with packed red blood cells
Number of subjects: 414
Study 20970213 — intervention group
Group type: EXPERIMENTAL
Intervention: High Hb levels
Number of subjects: 414
Study 20970213 — intervention group
Group type: COMPARATOR
Intervention: Low Hb no transfusion
Number of subjects: 414
Study 18490229 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterax (perindopril 2 mg and indapamide 0.625 mg)
Number of subjects: 41
Study 18490229 — intervention group
Group type: COMPARATOR
Intervention: Cilazapril (2.5 mg)
Number of subjects: 41
Study 16554495 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippocampal electrical stimulation (90 microsec, 190 Hz)
Number of subjects: 4
Study 16554495 — intervention group
Group type: COMPARATOR
Intervention: Hippocampal electrical stimulation OFF period
Number of subjects: 4
Study 16554495 — intervention group
Group type: COMPARATOR
Intervention: Baseline period
Number of subjects: 4
Study 15297776 — intervention group
Group type: EXPERIMENTAL
Intervention: Adsorptive granulocyte/monocyte apheresis (GMA) with up to 11 sessions over 10 weeks
Number of subjects: 69
Study 15297776 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone (PSL) increased to 30 mg/day/patient
Number of subjects: 69
Study 11738312 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical closure
Number of subjects: 521
Study 11738312 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 521
Study 9407412 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteinuria (measured by urine dipstick determinations)
Number of subjects: 12866
Study 9407412 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher and more persistent proteinuria
Number of subjects: 12866
Study 8136096 — intervention group
Group type: EXPERIMENTAL
Intervention: Continue HDFP medication
Number of subjects: 431
Study 8136096 — intervention group
Group type: COMPARATOR
Intervention: Discontinue medication with no dietary intervention
Number of subjects: 431
Study 8136096 — intervention group
Group type: COMPARATOR
Intervention: Discontinue medication with sodium restriction and potassium increase
Number of subjects: 431
Study 8136096 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight reduction intervention for overweight patients
Number of subjects: 431
Study 8136096 — intervention group
Group type: COMPARATOR
Intervention: Withdrawn from diuretic alone
Number of subjects: 431
Study 8136096 — intervention group
Group type: COMPARATOR
Intervention: Withdrawn from both diuretic plus reserpine
Number of subjects: 431
Study 3619842 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) 4 mg every 6 h for 48 h before and after altitude exposure
Number of subjects: 16
Study 3619842 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 29668691 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine Data Quality Assessments (RDQAs)
Number of subjects: 27
Study 29328639 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (0.2 mL of 0.8% gel)
Number of subjects: 60
Study 29328639 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid + aminocaproic acid (2 mL)
Number of subjects: 60
Study 29328639 — intervention group
Group type: COMPARATOR
Intervention: Alvogyl® (an anesthetic and antiseptic paste)
Number of subjects: 60
Study 23981570 — intervention group
Group type: EXPERIMENTAL
Intervention: Aroma exposure time of 18 seconds and high concentration (5 ×)
Number of subjects: 38
Study 23981570 — intervention group
Group type: COMPARATOR
Intervention: Aroma exposure time of 3 seconds and high concentration (5 ×)
Number of subjects: 38
Study 23981570 — intervention group
Group type: COMPARATOR
Intervention: Aroma exposure time of 18 seconds and low concentration (not specified)
Number of subjects: 38
Study 23981570 — intervention group
Group type: COMPARATOR
Intervention: Aroma exposure time of 3 seconds and low concentration (not specified)
Number of subjects: 38
Study 22948448 — intervention group
Group type: EXPERIMENTAL
Intervention: Female athletes
Number of subjects: 149
Study 22948448 — intervention group
Group type: COMPARATOR
Intervention: Female nonathletes
Number of subjects: 149
Study 21115926 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin (CBDCA) AUC 3 and Paclitaxel (PTX) 90 mg/m² (PCb arm)
Number of subjects: 75
Study 21115926 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin (CBDCA) AUC 3 plus Gemcitabine (GEM) 1000 mg/m² (GCb arm)
Number of subjects: 75
Study 19049301 — intervention group
Group type: EXPERIMENTAL
Intervention: Brinzolamide 1%/timolol 0.5%
Number of subjects: 94
Study 19049301 — intervention group
Group type: COMPARATOR
Intervention: Dorzolamide 2%/timolol 0.5%
Number of subjects: 94
Study 16805934 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg of gabapentin
Number of subjects: 90
Study 16805934 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg of gabapentin
Number of subjects: 90
Study 16805934 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 12391112 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 8
Study 12391112 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise session (Control)
Number of subjects: 8
Study 10450387 — intervention group
Group type: EXPERIMENTAL
Intervention: Multipurpose disinfecting solution
Number of subjects: 150
Study 10450387 — intervention group
Group type: EXPERIMENTAL
Intervention: One-step hydrogen peroxide
Number of subjects: 150
Study 10450387 — intervention group
Group type: EXPERIMENTAL
Intervention: One-step hydrogen peroxide and multipurpose solutions
Number of subjects: 150
Study 7480237 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (single oral dose taken at 8 P.M. the day before surgery)
Number of subjects: 339
Study 7480237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 339
Study 7480237 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 339
Study 2507125 — intervention group
Group type: EXPERIMENTAL
Intervention: LC9018 with radiation therapy
Number of subjects: 61
Study 4854116 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole blood replacement
Number of subjects: 27
Study 4854116 — intervention group
Group type: COMPARATOR
Intervention: Plasma replacement
Number of subjects: 27
Study 4854116 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran 75 replacement
Number of subjects: 27
Study 31308312 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Thompson procedure (Group 2)
Number of subjects: 26
Study 31308312 — intervention group
Group type: COMPARATOR
Intervention: Original Thompson procedure (Group 1)
Number of subjects: 26
Study 28621047 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR group (27 women)
Number of subjects: 54
Study 28621047 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment group (27 women)
Number of subjects: 54
Study 26450544 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological support for caregivers (Group 1)
Number of subjects: 48
Study 26450544 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 2)
Number of subjects: 48
Study 23588866 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient controlled epidural bolus (HKEB)
Number of subjects: 45
Study 23588866 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural infusion (SEI)
Number of subjects: 45
Study 21473826 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiration holding group
Number of subjects: 12
Study 21473826 — intervention group
Group type: COMPARATOR
Intervention: Automatic measurement group
Number of subjects: 12
Study 18505746 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised treadmill walking training
Number of subjects: 11
Study 18505746 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control stage
Number of subjects: 11
Study 17197845 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 32
Study 17197845 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 32
Study 15114090 — intervention group
Group type: EXPERIMENTAL
Intervention: CI-sparing regimen (sirolimus + reduced dose tacrolimus)
Number of subjects: 70
Study 15114090 — intervention group
Group type: COMPARATOR
Intervention: CI-free regimen (sirolimus + mycophenolate mofetil)
Number of subjects: 70
Study 15114090 — intervention group
Group type: EXPERIMENTAL
Intervention: CI-sparing regimen
Number of subjects: 70
Study 15114090 — intervention group
Group type: COMPARATOR
Intervention: CI-free regimen
Number of subjects: 70
Study 15114090 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 70
Study 11602544 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dofetilide (6, 9, and 15 microgram/kg)
Number of subjects: 51
Study 11602544 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dofetilide (1.5 and 3 microgram/kg)
Number of subjects: 51
Study 11602544 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dofetilide
Number of subjects: 51
Study 9534677 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal hepatitis B vaccine
Number of subjects: 42
Study 9534677 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular hepatitis B vaccine
Number of subjects: 42
Study 9534677 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed type hypersensitivity (DTH) test
Number of subjects: 42
Study 7996804 — intervention group
Group type: EXPERIMENTAL
Intervention: High flux polysulfone (HF-PS) membranes
Number of subjects: 9
Study 7996804 — intervention group
Group type: COMPARATOR
Intervention: Low flux polymethylmethacrylate (LF-PMMA) membranes
Number of subjects: 9
Study 7996804 — intervention group
Group type: COMPARATOR
Intervention: Cellulosic (cuprophane-CU) membranes
Number of subjects: 9
Study 7996804 — intervention group
Group type: EXPERIMENTAL
Intervention: High flux polysulfone (HF-PS) membranes (sixth reuse)
Number of subjects: 9
Study 3455953 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (0.6 mg/kg)
Number of subjects: 12
Study 3455953 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride (control)
Number of subjects: 12
Study 29112625 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic Preconditioning (IPC)
Number of subjects: 13
Study 29112625 — intervention group
Group type: COMPARATOR
Intervention: SHAM
Number of subjects: 13
Study 27000105 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory glucose profile (continuous glucose monitoring)
Number of subjects: 87
Study 27000105 — intervention group
Group type: COMPARATOR
Intervention: Capillary glucose testing (control)
Number of subjects: 87
Study 24305063 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg testosterone enanthate
Number of subjects: 121
Study 24305063 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg testosterone enanthate
Number of subjects: 121
Study 24305063 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg testosterone enanthate
Number of subjects: 121
Study 24305063 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg testosterone enanthate
Number of subjects: 121
Study 24305063 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg testosterone enanthate
Number of subjects: 121
Study 24305063 — intervention group
Group type: COMPARATOR
Intervention: Control group (no testosterone)
Number of subjects: 121
Study 22440993 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient Diabetes Management Program (IDMP)
Number of subjects: 22
Study 22440993 — intervention group
Group type: COMPARATOR
Intervention: Usual education only (non-IDMP group)
Number of subjects: 22
Study 22440993 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 22
Study 20464814 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing 14.1% oxygen (hypoxia) at low photopic (28 cd x m(‐2)), borderline upper mesopic (approximately 2.1 cd x m(‐2)), and midmesopic (approximately 0.26 cd x m(‐2)) luminance
Number of subjects: 12
Study 20464814 — intervention group
Group type: COMPARATOR
Intervention: Breathing air at sea level (normoxia) at low photopic (28 cd x m(‐2)), borderline upper mesopic (approximately 2.1 cd x m(‐2)), and midmesopic (approximately 0.26 cd x m(‐2)) luminance
Number of subjects: 12
Study 20464814 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing 100% oxygen (hyperoxia) at mesopic luminance
Number of subjects: 12
Study 18639360 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral Arm Training with Rhythmic Auditory Cueing (BATRAC)
Number of subjects: 18
Study 18639360 — intervention group
Group type: COMPARATOR
Intervention: Dose Matched Therapeutic Exercises (DMTE)
Number of subjects: 18
Study 18639360 — intervention group
Group type: EXPERIMENTAL
Intervention: BATRAC
Number of subjects: 18
Study 18639360 — intervention group
Group type: COMPARATOR
Intervention: DMTE
Number of subjects: 18
Study 17919964 — intervention group
Group type: EXPERIMENTAL
Intervention: Bridging social capital (contact amongst local friends)
Number of subjects: 9000
Study 17919964 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonding social capital (attachment to neighbourhood)
Number of subjects: 9000
Study 15196721 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-assisted ICSI
Number of subjects: 280
Study 15196721 — intervention group
Group type: COMPARATOR
Intervention: Conventional ICSI
Number of subjects: 280
Study 11739462 — intervention group
Group type: EXPERIMENTAL
Intervention: E2 supplementation (1 mg micronized 17 beta‐E2 orally twice daily for 6‐23 days)
Number of subjects: 9
Study 11739462 — intervention group
Group type: EXPERIMENTAL
Intervention: E2 supplementation
Number of subjects: 9
Study 11739462 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 9
Study 9241570 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg o.d.) + Pindolol (2.5 mg t.d.s.)
Number of subjects: 54
Study 9241570 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg or 40 mg) after the trial
Number of subjects: 54
Study 9241570 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine (20 mg o.d.) + Placebo
Number of subjects: 54
Study 8309737 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside pulmonary mechanics testing (PM)
Number of subjects: 468
Study 3789294 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 0
Study 3789294 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 0
Study 3789294 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxalactam
Number of subjects: 0
Study 3789294 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 31728894 — intervention group
Group type: EXPERIMENTAL
Intervention: PreView intervention
Number of subjects: 508
Study 31728894 — intervention group
Group type: COMPARATOR
Intervention: Control group (video about healthy lifestyle)
Number of subjects: 508
Study 30543803 — intervention group
Group type: EXPERIMENTAL
Intervention: ParticiPAte CP (8-week goal-directed, individualized, participation-focused therapy delivered by a physical therapist)
Number of subjects: 37
Study 30543803 — intervention group
Group type: EXPERIMENTAL
Intervention: ParticiPAte CP
Number of subjects: 37
Study 30543803 — intervention group
Group type: COMPARATOR
Intervention: Usual care (waitlist control)
Number of subjects: 37
Study 28089468 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA)
Number of subjects: 101
Study 28089468 — intervention group
Group type: COMPARATOR
Intervention: Control (Normal Saline)
Number of subjects: 101
Study 23609832 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic Ponzo illusion
Number of subjects: 0
Study 23609832 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified right Ponzo illusion
Number of subjects: 0
Study 23609832 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified left Ponzo illusion
Number of subjects: 0
Study 23609832 — intervention group
Group type: EXPERIMENTAL
Intervention: Canonical illusion vs. modified right illusion
Number of subjects: 0
Study 23609832 — intervention group
Group type: EXPERIMENTAL
Intervention: Single case analysis in neglect group
Number of subjects: 0
Study 23609832 — intervention group
Group type: COMPARATOR
Intervention: Control condition with parallel lines
Number of subjects: 0
Study 21311746 — intervention group
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation (tDCS) to the anterior temporal lobes (ATL)
Number of subjects: 60
Study 21311746 — intervention group
Group type: COMPARATOR
Intervention: sham stimulation (control)
Number of subjects: 60
Study 19554657 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium phosphate plus 240 mg of tablet simethicone
Number of subjects: 124
Study 19554657 — intervention group
Group type: COMPARATOR
Intervention: Sodium phosphate plus placebo
Number of subjects: 124
Study 16773549 — intervention group
Group type: EXPERIMENTAL
Intervention: DMP participants
Number of subjects: 20
Study 16773549 — intervention group
Group type: COMPARATOR
Intervention: Non-participants
Number of subjects: 20
Study 16773549 — intervention group
Group type: EXPERIMENTAL
Intervention: DMP participants (younger than 70 years)
Number of subjects: 20
Study 15586301 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepivacaine 4% with 0.1 mg of morphine
Number of subjects: 40
Study 15586301 — intervention group
Group type: COMPARATOR
Intervention: Mepivacaine 4% with saline (placebo)
Number of subjects: 40
Study 11141143 — intervention group
Group type: EXPERIMENTAL
Intervention: Known diabetes
Number of subjects: 4662
Study 11141143 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA(1c) concentration
Number of subjects: 4662
Study 11141143 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA(1c) concentration >/=5%
Number of subjects: 4662
Study 11141143 — intervention group
Group type: COMPARATOR
Intervention: Men with known diabetes excluded
Number of subjects: 4662
Study 8989179 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium infusion
Number of subjects: 18
Study 8989179 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 18
Study 8480475 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexfenfluramine
Number of subjects: 10
Study 2979673 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine 50 mg
Number of subjects: 10
Study 2979673 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine 100 mg
Number of subjects: 10
Study 2979673 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine 150 mg
Number of subjects: 10
Study 2979673 — intervention group
Group type: EXPERIMENTAL
Intervention: Propantheline 15 mg
Number of subjects: 10
Study 2979673 — intervention group
Group type: EXPERIMENTAL
Intervention: Propantheline 45 mg
Number of subjects: 10
Study 2979673 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine
Number of subjects: 10
Study 31053513 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1600 IU/day vitamin D3)
Number of subjects: 154
Study 31053513 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 28279085 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Group (EG) - Aquatic activities 3 times a week from weeks 10-12 to 38-39 of gestation
Number of subjects: 111
Study 28279085 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - No aquatic activities
Number of subjects: 111